Aap implants
| aap Implantate AG
|
|
|---|---|
 |
|
| legal form | AG |
| ISIN | DE0005066609 |
| founding | 1990 |
| Seat |
Berlin , Germany
|
| management | Rubino Di Girolamo |
| Number of employees | 148 (2018) |
| sales | 11 million euros (2018) |
| Branch | Medical technology |
| Website | www.aap.de |
| As of December 31, 2018 | |
Aap Implantate AG ( own spelling : aap ) is a Berlin- based listed medical technology company .
Companies
The company operated as a subsidiary of the US pharmaceutical and consumer goods manufacturer Johnson & Johnson until 1990 as Mecron . It develops, manufactures and sells biomaterials and implants for use in orthopedics . The products such as cannulated screws, standard plates, bone cement and bone replacement materials are used in traumatology and spine surgery .
The company's IPO , at that time still on the Neuer Markt , took place on May 10, 1999; it has been listed in the Prime Standard segment since 2003 . The issue price of par value bearer - shares was 10 euros. In 2004 Aap had 100 employees.
organization
The following people have been members of the Management Board and Supervisory Board since May 2019:
Board
- Rubino Di Girolamo, Chairman of the Board
- Marek Hahn, member of the board of directors
Supervisory board
- Biense Visser, chairman of the supervisory board
- Jacqueline Rijsdijk, Deputy Chairwoman of the Supervisory Board
- Natalie Krebs, member of the supervisory board
Web links
Individual evidence
- ↑ aap Implantate AG | Board. Retrieved September 11, 2019 .
- ↑ a b Annual Report 2018. (pdf) In: aap.de. Retrieved August 27, 2019 .
- ↑ Cash injection saves the Berlin Aap implants from collapse . In: Berliner Morgenpost , May 30, 2004, accessed on January 26, 2014.